CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab
Clinical trial NCT05121038 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05121038
- Sponsor
- Anup Kasi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2025-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.